Skip to main content
Back to Gaingels

Gaingels's Life Science Portfolio

Browse 18 Life Science companies funded by Gaingels. See funding amounts, founder contacts, and investment details.

Life Science Companies
18
Total Funding in Life Science
$379.1M

Life Science Portfolio Companies (18)

Export
BiotechnologyHealth CareLife ScienceMedical

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Watertown, United States
September 2024
$25.0M
Series B

Founder Contacts

41,000+ verified contacts

Assistive TechnologyBiotechnologyeSportsGamingLife ScienceMedicalMedical DeviceMilitaryNeuroscienceTherapeutics

Sharper Sense is a wearable patch that stimulates a neck nerve to improve hearing, vision, and touch.

New York, United States
July 2026
$100K
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Santa Ana, United States
July 2025
$2.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceRobotics

Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.

San Francisco, United States
May 2025
$8.0M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$48.0M
Series A

Founder Contacts

41,000+ verified contacts

Clinical TrialsHealth CareLife ScienceSoftware

Curebase is the modern eClinical platform for faster study builds, better engagement, and seamless data capture.

San Francisco, United States
May 2022
$40.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.

Berkeley, United States
May 2024
$2.4M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
$40.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsLife Science

Minicircle develops a human genetic enhancement platform to facilitate life extension capabilities.

Los Angeles, United States
April 2024
$459K
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
$15K
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Los Angeles, United States
March 2026
$10.4M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

New York, United States
September 2025
$38.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife SciencePharmaceutical

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

Menlo Park, United States
July 2025
$8.9M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical

Ignota Labs recognizes that safety errors during the drug discovery process.

London, United Kingdom
February 2025
$6.9M
Seed

Founder Contacts

41,000+ verified contacts

Explore Gaingels's Full Portfolio

View all companies funded by Gaingels across every industry and funding stage.

View Full Gaingels Portfolio